(20 days)
No
The document describes standard ECG analysis techniques and does not mention AI or ML.
No.
The device is intended to acquire, analyze, display, and record electrocardiographic information, which is diagnostic in nature, not therapeutic.
Yes
The device is intended to acquire, analyze, display, and record electrocardiographic information, including "12 lead interpretive analysis," which provides diagnostic information about the heart's electrical activity.
No
The device description explicitly states that the device consists of two basic components: the processing unit and patient acquisition module, indicating hardware components beyond just software.
Based on the provided text, the MAC 5000 ECG Analysis System is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- The MAC 5000 acquires, analyzes, displays, and records electrocardiographic information directly from the patient's body using surface electrodes. This is a non-invasive measurement of electrical activity, not an analysis of a biological specimen.
The description clearly states it acquires ECG signals from "surface ECG electrodes" and is used to "acquire, analyze, display, and record electrocardiographic information from adult and pediatric populations." This aligns with the definition of a device that measures physiological signals directly from the body, not an IVD.
N/A
Intended Use / Indications for Use
The MAC 5000 ECG Analysis System is intended to acquire, analyze, display, and record electrocardiographic information from adult and pediatric populations. Basic systems deliver 3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be upgraded to provide software analysis options such as high resolution signal averaging of QRS and P wave portions of the electrocardiogram. Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional.
The MAC 5000 is intended to be used under the direct supervision of a licensed healthcare practitioner, by trained operators in a hospital or medical professional's facility.
Product codes
74DQH, 74DXH, 74DPS, 74LOS, 74DSI, MHX
Device Description
The Mac 5000 ECG Analysis System is designed to acquire, analyze, display, and record ECG signals from surface ECG electrodes. The device consists of two basic components: the processing unit and patient acquisition module. Models provide rechargeable battery operation and/or optional trolley for transporting the equipment.
The MAC 5000 can deliver 3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be upgraded to provide software analysis options such as high resolution signal averaging of QRS and P wave portions of the electrocardiogram. Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional.
The MAC 5000 system acquires ECG data using a modular patient
data acquisition device called the CAM14 (K991735). By placing the data acquisition device closer to the patient, signal fidelity is improved and noise is reduced. MAC 5000 delivers 12 or 15 lead ECG's on full-size reports with alphanumeric keyboard for patient demographic and other data entry, a full-size VGA graphics and waveform display, integrated thermal writer and removable data storage.
Additionally, the MAC 5000 utilizes battery power for customer convenience and can transmit and receive ECGs to and from a central ECG cardiovascular information system via optional communication links. The system is intended as a mobile device but the main unit can be separated from the trolley and used as a desktop unit.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult and pediatric populations.
Intended User / Care Setting
licensed healthcare practitioner, by trained operators in a hospital or medical professional's facility.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The MAC 5000 complies with the voluntary standards as detailed in Section 9 of this submission.
The following quality assurance measures were applied to the development of the MAC 5000.
Requirements specification reviews
Code inspections
Software and hardware testing
Safety testing
Environmental testing
Final system validation
The results of these measurements demonstrate that the MAC 5000 is as safe, effective, and performs as well as the predicate device.
Key Metrics
Not Found
Predicate Device(s)
Mac 5000 Rest ECG Analysis System with ST Option (K014108)
Reference Device(s)
ECG Analysis Program 12SL (K002209), Phi Res Algorithm (K972199), CAM14 (K991735)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
K033492
-page 1 of 2
NOV 2 4 2003
| 510(k) Summary of Safety and Effectiveness | |
|---|---|
| -- | -------------------------------------------- |
October 30, 2003 Date:
GE Medical Systems - Information Technologies Submitter: 8200 W. Tower Ave. Milwaukee, WI 53223 USA
Contact Person: Lisa Lee Michels GE Medical Systems - Information Technologies Phone: (262) 293-1609 Fax: (414) 918-8203
David Wahlig Contact Person: GE Medical Systems - Information Technologies Phone: (262) 293-1705 Fax: (414) 918-8112
Trade/Proprietary Name: MAC 5000 ECG Analysis System
Common/Usual Name: Electrocardiograph
Classification Names & Citations:
| 21 CFR 870.1425 Programmable diagnostic computer | 74DQH |
|---|---|
| 21 CFR 870.2920 Transmitters and Receivers, Electrocardiograph, Telephone | 74DXH |
| 21 CFR 870.2340 Electrocardiograph | 74DPS |
| 21 CFR 870.2340 System, ECG Analysis | 74LOS |
| 21 CFR 870.1025 Detector and Alarm, Arrhythmia | 74DSI |
Predicate Devices: Mac 5000 Rest ECG Analysis System with ST Option (K014108).
All algorithms have been previously cleared and include: ECG Analysis Program 12SL (K002209) Phi Res Algorithm (K972199)
The Mac 5000 ECG Analysis System is designed to acquire, analyze, Device Description: display, and record ECG signals from surface ECG electrodes. The device consists of two basic components: the processing unit and patient acquisition module. Models provide rechargeable battery operation and/or optional trolley for transporting the equipment.
The MAC 5000 can deliver 3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be upgraded to provide software analysis options such as high resolution signal averaging of QRS and P wave portions of the electrocardiogram. Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional.
The MAC 5000 system acquires ECG data using a modular patient
1
data acquisition device called the CAM14 (K991735). By placing the data acquisition device closer to the patient, signal fidelity is improved and noise is reduced. MAC 5000 delivers 12 or 15 lead ECG's on full-size reports with alphanumeric keyboard for patient demographic and other data entry, a full-size VGA graphics and waveform display, integrated thermal writer and removable data storage.
Additionally, the MAC 5000 utilizes battery power for customer convenience and can transmit and receive ECGs to and from a central ECG cardiovascular information system via optional communication links. The system is intended as a mobile device but the main unit can be separated from the trolley and used as a desktop unit.
- The MAC 5000 ECG Analysis System is intended to be used under Intended Use: the direct supervision of a licensed healthcare practitioner. The MAC 5000 is intended to be used by trained operators in a hospital or medical professional's facility environment to record ECG signals from surface electrodes. The device is intended to acquire, analyze. display, and record electrocardiographic information from adult and pediatric populations.
- Technology: The technological characteristics of the MAC 5000 device have been updated to reflect use of current technology and to incorporate userrequested features. Data in this submission demonstrate that these technological characteristics do not raise new questions of safety or effectiveness.
- Test Summary: The MAC 5000 complies with the voluntary standards as detailed in Section 9 of this submission.
The following quality assurance measures were applied to the development of the MAC 5000.
- . Requirements specification reviews
- . Code inspections
- Software and hardware testing .
- Safety testing ●
- . Environmental testing
- . Final system validation
- Conclusion: The results of these measurements demonstrate that the MAC 5000 is as safe, effective, and performs as well as the predicate device.
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three wavy lines representing its wings and body. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 2 4 2003
GE Medical Systems Information Technologies c/o Ms. Lisa Lee Michels Regulatory Affairs Specialist 8200 West Tower Avenue Milwaukee, WI 53223
Re: K033492
Trade Name: MAC 5000 ECG Analysis System Regulation Number: 21 CFR 870.1025 Regulation Name: Patient Physiological Monitor (arrhythmia detector and alarm) Regulatory Class: Class III (three) Product Code: MHX Dated: October 30, 2003 Received: November 4, 2003
Dear Ms. Michels:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 -- Ms. Lisa Lee Michels
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
стаделтар
Bram D Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):
Unknown;
510(k) filed on 13 December, 2001
Page 1 of 1
MAC 5000 ECG Analysis System Device Name:
Indications For Use:
The MAC 5000 ECG Analysis System is intended to acquire, analyze, display, and record electrocardiographic information from adult and pediatric populations. Basic systems deliver 3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be upgraded to provide software analysis options such as high resolution signal averaging of QRS and P wave portions of the electrocardiogram. Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional.
The MAC 5000 is intended to be used under the direct supervision of a licensed healthcare practitioner, by trained operators in a hospital or medical professional's facility.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Divis
Division:
ular Devices
510(k) Num
K033492
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter
Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)